Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

POWERSHARES DYNAMIC BIOTECHNOLOGY-GENOME: (PBE)

(Delayed quote from AMEX) As of Sep 23, 2014 03:59 PM ET

 Add to portfolio

$46.12 USD

-0.39 (-0.84%)

Volume: 34,934

Zacks ETF Rank: 2 - Buy [?]   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 46.51
Open 45.28
Bid 45.22
Ask 46.44
Day Low-High 46.11-46.68
52wk Low-High 33.04-48.12
Volume 34,934
NAV (month end) 47.78
Premium (+)/Discount (-) (month end)-1.27

Zacks Premium Research for PBE

Zacks ETF Rank [?] Buy 2
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.63%
Dividend (Yield) $0.23 (0.51%)
Issuer INVESCO POWERSHARES

Benchmark for PBE

DYNAMIC BIOTECHNOLOGY-GENOME INTELLIDEX

This is comprised of stocks of 30 U.S. biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

Fund Summary for PBE

POWERSHARES DYNAMIC BIOTECHNOLOGY-GENOME

It is based on the Dynamic Biotechnology & Genome Intellidex Index. It invests at least 90% of its total assets in common stocks that comprise the Index which provides capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.